Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients.
J Nephrol
; 35(3): 783-785, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-35192157
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peritoneal Dialysis
/
BNT162 Vaccine
Limits:
Humans
Language:
En
Journal:
J Nephrol
Journal subject:
NEFROLOGIA
Year:
2022
Type:
Article
Affiliation country:
France